Exton Michael
Lexicon Pharmaceuticals, Inc. · Chief Executive Officer
Exton Michael is listed in public filings as director, officer: Chief Executive Officer. This Exton Michael insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Lexicon Pharmaceuticals, Inc. (LXRX). Investors use Exton Michael's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $439k298.4k shares | Grant / ExerciseFeb 28, 2026 | $301.1K204.8k shares | $1.47 | -- | |
| --503.3k shares | Grant / ExerciseFeb 28, 2026 | Disclosure amount unavailable503.3k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.8M1.3M shares | Grant / ExerciseFeb 12, 2026 | $1.8M1.3M shares | $1.37 | -- | |
| --862.4k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable862.4k shares | -- | -- | |
| $1.6M2.3M shares | Grant / ExerciseFeb 13, 2025 | $1.6M2.3M shares | $0.695 | -- | |
| --1.5M shares | Grant / ExerciseFeb 13, 2025 | Disclosure amount unavailable1.5M shares | -- | -- | |
| $2.8M1.7M shares | Grant / ExerciseJul 8, 2024 | $2.8M1.7M shares | $1.67 | -- |